Epigral Ltd (EPIGRAL) Q2FY27 Management Mirror - Sep-2026 Qtr
Q2 FY27 EBITDA Margin Reported at 18.2%, Falling Short of 22%-23% Guidance Issued in Mar'26 Qtr
Epigral Ltd reported a Q2 FY27 EBITDA margin of 18.2% in its Quarterly Financial Results and 18% in the concall. This fell short of the Mar'26 Qtr guidance, which aimed to maintain margins in the achieved 22% to 23% range, as the company faced pressure from rising coal and energy prices alongside global uncertainties affecting finished goods prices. Looking ahead, management expects realizations for caustic soda and PVC/CPVC to increase in Q3 and Q4 FY27 due to higher winter energy costs in Europe and historical seasonality favoring H2 over H1.
3 more themes on the ELITE plan.